phenytoin has been researched along with Cerebral Palsy in 8 studies
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phenytoin-induced gingival overgrowth (PIGO) is a recognized side effect in many cerebral palsy patients using diphenylhydantoin (Dph) for the control of seizures." | 7.67 | Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population. ( Jones, JE; McKown, CG; Weddell, JA, 1988) |
| " A more severe grade of neonatal encephalopathy, a higher number of neonatal seizures, the neonatal use of phenytoin, diffuse abnormalities on imaging, and abnormal findings on neurologic examination at neonatal discharge were all significantly (P<0." | 3.75 | The spectrum of abnormal neurologic outcomes subsequent to term intrapartum asphyxia. ( Al-Macki, N; Hall, N; Miller, SP; Shevell, M, 2009) |
| "Phenytoin-induced gingival overgrowth (PIGO) is a recognized side effect in many cerebral palsy patients using diphenylhydantoin (Dph) for the control of seizures." | 3.67 | Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population. ( Jones, JE; McKown, CG; Weddell, JA, 1988) |
| "Cerebral palsy was not diagnosed in any infant of a hypertensive mother compared with five of the controls." | 1.30 | Maternal hypertension and neurodevelopmental outcome in very preterm infants. ( Burns, YR; Gray, PH; King, JF; Mohay, HA; O'Callaghan, MJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, R | 1 |
| Hayashi, R | 1 |
| Umemori, Y | 1 |
| Arimatsu, A | 1 |
| Yuki, A | 1 |
| Abe, R | 1 |
| Al-Macki, N | 1 |
| Miller, SP | 1 |
| Hall, N | 1 |
| Shevell, M | 1 |
| Gray, PH | 1 |
| O'Callaghan, MJ | 1 |
| Mohay, HA | 1 |
| Burns, YR | 1 |
| King, JF | 1 |
| Higashi, A | 1 |
| Matsuda, I | 1 |
| Sinosuka, S | 1 |
| Ohtsuka, H | 1 |
| Endo, F | 1 |
| Maeda, T | 1 |
| Ikeda, T | 1 |
| Miyoshino, S | 1 |
| Rodriguez-Segade, S | 1 |
| de la Peña, CA | 1 |
| Tutor, JC | 1 |
| Paz, JM | 1 |
| Fernandez, MP | 1 |
| Rozas, I | 1 |
| Del Río, R | 1 |
| Jones, JE | 1 |
| Weddell, JA | 1 |
| McKown, CG | 1 |
| Ota, N | 1 |
| Murakami, H | 1 |
| Hashimoto, K | 1 |
| Watanabe, T | 1 |
| Kasahara, H | 1 |
| Tokuue, S | 1 |
| Trojaborg, W | 1 |
8 other studies available for phenytoin and Cerebral Palsy
| Article | Year |
|---|---|
Refractory Bullous Pemphigoid Improved by Discontinuation of Phenytoin as an CYP3A4 Inducer.
Topics: Aged; Anti-Inflammatory Agents; Anticonvulsants; Cerebral Palsy; Cytochrome P-450 CYP3A Inducers; Dr | 2020 |
The spectrum of abnormal neurologic outcomes subsequent to term intrapartum asphyxia.
Topics: Anticonvulsants; Asphyxia Neonatorum; Cerebral Palsy; Female; Follow-Up Studies; Humans; Infant, New | 2009 |
Maternal hypertension and neurodevelopmental outcome in very preterm infants.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Case-Control Studies; Cerebral Palsy; Child, Presch | 1998 |
Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.
Topics: Adolescent; B-Lymphocytes; Cerebral Palsy; Child; Child, Preschool; Disabled Persons; Humans; Immuni | 1978 |
Carnitine deficiency associated with anticonvulsant therapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Carnitine; Cerebral Palsy; Drug Therapy, Co | 1989 |
Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population.
Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, General; Cerebral | 1988 |
[A case of dilantin hyperplasia associated with cerebral palsy].
Topics: Adult; Cerebral Palsy; Dental Scaling; Gingival Hyperplasia; Humans; Male; Oral Hygiene; Phenytoin; | 1987 |
Focal spike discharges in children, a longitudinal study.
Topics: Adolescent; Aging; Central Nervous System Diseases; Cerebral Palsy; Cerebral Ventriculography; Child | 1966 |